What is Ankylosing Spondylitis?

What is Ankylosing Spondylitis?

Ankylosing Spondylitis, or AS, is an inflammatory arthritis that mainly affects the spine. Inflammation of the spinal joints can cause stiffness and pain. Over time, the vertebrae can fuse, decreasing flexibility and resulting in a loss of mobility in the spine. These malformations can have a domino effect on other areas of the body and can cause pain and stiffness in the shoulders, hips, and ribs. Small joints in the hands and feet, as well as the heel can also be affected, in addition to inflammation of the eyes. Pain is commonly described as dull aching and is worse in the morning or after prolonged immobility.

Who Suffers From Ankylosing Spondylitis?

Most people think that AS is more common in men than women, but recent data has shown AS occurs equally in both. Symptoms usually begin in teens to early adulthood but can be diagnosed at any time. To diagnose AS, a provider will likely do a thorough physical, imaging, blood work (looking for a specific gene), and gather medical history (including family history of AS).

How Can You Treat Ankylosing Spondylitis?

Treatment for Ankylosing Spondylitis focuses on reducing pain and preventing or delaying spinal fusion or other complications. As with many chronic conditions, early intervention produces better treatment results. Common medications include:

Biologic DMARDS

In addition to medication, physical therapy can help to maintain flexibility and strength.

What is Clinvest’s Role?

Clinvest knows how challenging and frustrating head pain can be. With conditions such as Ankylosing Spondylitis, we have a strong commitment to further treatment and research. Here at Clinvest we partner with pharmaceutical companies in effort to find more solutions for such debilitating conditions and look forward to the new horizons in health and well-being.